Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,305 | 61,117 | 99,394 | 98,991 | 89,265 |
| Marketable Securities | 166,381 | 202,939 | 201,236 | 204,882 | 206,716 |
| Receivables | 12,324 | 12,981 | 13,872 | 14,543 | 13,321 |
| Inventories | 5,388 | 5,142 | 5,351 | 4,318 | 4,369 |
| TOTAL | $278,917 | $286,803 | $325,807 | $325,339 | $319,658 |
| Non-Current Assets | |||||
| PPE Net | 3,455 | 3,042 | 3,230 | 2,717 | 2,540 |
| Investments And Advances | 15,000 | 15,000 | 0 | 0 | 0 |
| Intangibles | 188,421 | 189,492 | 185,753 | 180,505 | 181,304 |
| Other Non-Current Assets | 5,351 | 6,457 | 5,556 | 11,949 | 3,628 |
| TOTAL | $212,227 | $213,991 | $194,539 | $195,171 | $187,472 |
| Total Assets | $491,144 | $500,794 | $520,346 | $520,510 | $507,130 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,847 | 9,423 | 18,938 | 7,370 | 9,076 |
| Accrued Expenses | 35,270 | 31,644 | 36,018 | 32,253 | 27,597 |
| Other current liabilities | 14,979 | 15,458 | 30,712 | 43,129 | 42,953 |
| TOTAL | $103,497 | $56,525 | $85,668 | $83,904 | $79,626 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 99,658 | 144,794 | 141,544 | 132,086 | 130,489 |
| TOTAL | $99,658 | $144,794 | $141,544 | $132,086 | $131,675 |
| Total Liabilities | $203,155 | $201,319 | $227,212 | $215,990 | $211,301 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,427 | 39,944 | 39,693 | 39,307 | 38,385 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -208,046 | -185,717 | -177,655 | -160,037 | -142,243 |
| Other shareholders' equity | -1,152 | -1,529 | -1,015 | -595 | -576 |
| TOTAL | $287,989 | $299,475 | $293,134 | $304,520 | $295,829 |
| Total Liabilities And Equity | $491,144 | $500,794 | $520,346 | $520,510 | $507,130 |